
A Bradford researcher has discovered a potential new drug which could tackle an aggressive type of breast cancer.
Professor Mohamed El-Tanani from the University of Bradford’s Institute for Cancer Therapeutics has been working with colleagues from Ulster University, Sunderland and Queen’s University Belfast to come up with this new drug that attacks cancer cells.
Laboratory tests have shown when the drug is added to hard-to-treat breast cancer cells, the cells actively take it in and their growth rate is reduced.
Professor El-Tanani has said: “By developing a nanoparticle that can help this peptide enter triple negative breast cancer cells and block RAN we’ve brought this potential new treatment a step closer to the clinic.”